Androgen-deprivation therapy in prostate cancer and cardiovascular risk: A science advisory from the American heart association, American cancer society, and American urological association: Endorsed by the American society for radiation oncology

Glenn N. Levine; Anthony V. D'Amico; Peter Berger; Peter E. Clark; Robert H. Eckel; Nancy L. Keating; Richard V. Milani; Arthur I Sagalowsky; Matthew R. Smith; Neil Zakai

doi:10.3322/caac.20061

Androgen-deprivation therapy in prostate cancer and cardiovascular risk: A science advisory from the American heart association, American cancer society, and American urological association: Endorsed by the American society for radiation oncology

Glenn N. Levine, Anthony V. D'Amico, Peter Berger, Peter E. Clark, Robert H. Eckel, Nancy L. Keating, Richard V. Milani, Arthur I Sagalowsky, Matthew R. Smith, Neil Zakai

Research output: Contribution to journal › Article › peer-review

156 Scopus citations

Original language	English (US)
Pages (from-to)	194-201
Number of pages	8
Journal	CA Cancer Journal for Clinicians
Volume	60
Issue number	3
DOIs	https://doi.org/10.3322/caac.20061
State	Published - May 2010

ASJC Scopus subject areas

Hematology
Oncology

Access to Document

10.3322/caac.20061

Cite this

Levine, G. N., D'Amico, A. V., Berger, P., Clark, P. E., Eckel, R. H., Keating, N. L., Milani, R. V., Sagalowsky, A. I., Smith, M. R., & Zakai, N. (2010). Androgen-deprivation therapy in prostate cancer and cardiovascular risk: A science advisory from the American heart association, American cancer society, and American urological association: Endorsed by the American society for radiation oncology. CA Cancer Journal for Clinicians, 60(3), 194-201. https://doi.org/10.3322/caac.20061

Androgen-deprivation therapy in prostate cancer and cardiovascular risk: A science advisory from the American heart association, American cancer society, and American urological association: Endorsed by the American society for radiation oncology. / Levine, Glenn N.; D'Amico, Anthony V.; Berger, Peter et al.
In: CA Cancer Journal for Clinicians, Vol. 60, No. 3, 05.2010, p. 194-201.

Research output: Contribution to journal › Article › peer-review

Levine, GN, D'Amico, AV, Berger, P, Clark, PE, Eckel, RH, Keating, NL, Milani, RV, Sagalowsky, AI, Smith, MR & Zakai, N 2010, 'Androgen-deprivation therapy in prostate cancer and cardiovascular risk: A science advisory from the American heart association, American cancer society, and American urological association: Endorsed by the American society for radiation oncology', CA Cancer Journal for Clinicians, vol. 60, no. 3, pp. 194-201. https://doi.org/10.3322/caac.20061

Levine GN, D'Amico AV, Berger P, Clark PE, Eckel RH, Keating NL et al. Androgen-deprivation therapy in prostate cancer and cardiovascular risk: A science advisory from the American heart association, American cancer society, and American urological association: Endorsed by the American society for radiation oncology. CA Cancer Journal for Clinicians. 2010 May;60(3):194-201. doi: 10.3322/caac.20061

Levine, Glenn N. ; D'Amico, Anthony V. ; Berger, Peter et al. / Androgen-deprivation therapy in prostate cancer and cardiovascular risk : A science advisory from the American heart association, American cancer society, and American urological association: Endorsed by the American society for radiation oncology. In: CA Cancer Journal for Clinicians. 2010 ; Vol. 60, No. 3. pp. 194-201.

@article{228eb7520b574aa49a822a4f086a1bb1,

title = "Androgen-deprivation therapy in prostate cancer and cardiovascular risk: A science advisory from the American heart association, American cancer society, and American urological association: Endorsed by the American society for radiation oncology",

author = "Levine, {Glenn N.} and D'Amico, {Anthony V.} and Peter Berger and Clark, {Peter E.} and Eckel, {Robert H.} and Keating, {Nancy L.} and Milani, {Richard V.} and Sagalowsky, {Arthur I} and Smith, {Matthew R.} and Neil Zakai",

year = "2010",

month = may,

doi = "10.3322/caac.20061",

language = "English (US)",

volume = "60",

pages = "194--201",

journal = "CA Cancer Journal for Clinicians",

issn = "0007-9235",

publisher = "Wiley-Blackwell",

number = "3",

}

TY - JOUR

T1 - Androgen-deprivation therapy in prostate cancer and cardiovascular risk

T2 - A science advisory from the American heart association, American cancer society, and American urological association: Endorsed by the American society for radiation oncology

AU - Levine, Glenn N.

AU - D'Amico, Anthony V.

AU - Berger, Peter

AU - Clark, Peter E.

AU - Eckel, Robert H.

AU - Keating, Nancy L.

AU - Milani, Richard V.

AU - Sagalowsky, Arthur I

AU - Smith, Matthew R.

AU - Zakai, Neil

PY - 2010/5

Y1 - 2010/5

UR - http://www.scopus.com/inward/record.url?scp=77952568266&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77952568266&partnerID=8YFLogxK

U2 - 10.3322/caac.20061

DO - 10.3322/caac.20061

M3 - Article

C2 - 20124400

AN - SCOPUS:77952568266

SN - 0007-9235

VL - 60

SP - 194

EP - 201

JO - CA Cancer Journal for Clinicians

JF - CA Cancer Journal for Clinicians

IS - 3

ER -

Androgen-deprivation therapy in prostate cancer and cardiovascular risk: A science advisory from the American heart association, American cancer society, and American urological association: Endorsed by the American society for radiation oncology

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this